inflammation3,4). Thus, ICE inhibitors would be useful as anti-inflammatory agents.
To discover novel anti-inflammatory drugs, we initiated a screening program to obtain ICE inhibitors from microbial sources5-9). We isolated novel ICE inhibitory compound.
EI-2128-1, from culture broths of Penicillium sp. strain E-2128. In this article, we describe the taxonomy and fermentation of the producing strain and isolation, structure elucidation, and biological properties of EI-2128-1.
Material and Methods

Material
Human recombinant ICE was prepared by heterologous expression of p10 and p20 subunits in Escherichia coli and in vitro refolding as described10). The enzyme was purified by ion exchange chromatography10). Acetyl-Tyr-Val-AlaAsp-amino-4-methylcoumarin (Ac-Tyr-Val-Ala-Asp-AMC)1), a fluorescent substrate was purchased from Peptide Institute, Inc., Osaka, Japan. All other chemicals were of analytical grade.
Taxonomy
The producing strain E-2128 was isolated from a soil sample. E-2128 was cultured on malt extract agar (malt extract 2%, glucose 2%, peptone 0.1% and agar 2%) and characteristics were determined after cultivation for 14 days. Morphological observations of strain E-2128 grown ascertained by light microscopy. The temperature range of growth was determined after cultivation with malt extract broth (malt extract 2%, glucose 2% and peptone 0.1%) for 7 days.
Culture and Medium Conditions A loopful of spores of E-2128, grown on an agar slant, was inoculated into each of three 50-ml test tubes containing 10ml of a seed medium composed of dried mashed potatoes 3%, glucose 10% and yeast extract 0.5% inoculated test tubes were incubated on a reciprocating added to a 300-ml Erlenmeyer flask containing 50ml of the same medium. Four inoculated flasks were incubated for 2 seed culture was transferred into a 300-ml Erlenmeyer flask containing 50ml of the fermentation medium composed of glucose 1%, soluble starch 1%, corn starch 1%, corn steep liquor 0.5%, Pharmamedia (IWAKI) 0.5%, dried yeast 0.5%, and calcium carbonate 0.2% in deionized water (pH 6.0 before sterilization). The fermentation was carried out Production of EI-2128-1 by Fermentation E-2128 was cultured in 300-ml Erlenmeyer flasks containing the fermentation medium described in Materials and Methods. The production of active materials in the culture broth initiated on day 3, and the amount of active materials reached maximum on day 6. Active materials were produced mainly in mycelia.
Isolation and Purification
The isolation procedure for the EI-2128-1 is shown schematically in Fig. 1 . The producing strain E-2128 was cultured according to the method described in the Materials and Methods. EI-2128-1 was purified from mycelia obtained by filtration of fermentation broth. The mycelia cake was extracted with 2 liters of methanol. The extract was diluted with 8 liters of deionized water and applied on a Diaion HP-20 column (400ml). After washing the column with 50% aqueous methanol (1.6 liters), the active principles were eluted from the column with methanol (1.6 liters). Active fractions containing EI-2128-1 were combined and diluted with an equal amount of deionized water. This aqueous solution was applied onto an ODS gel column (ODS-AQ-S50, 353ml) equilibrated with 50% methanol, and eluted with 75% methanol. Active fractions containing EI-2128-1 were pooled and concentrated in vacuo to yield crude EI-2128-1 (193mg) . This crude EI-2128-1 was dissolved in 19ml of methanol and purified by preparative HPLC using a column (D-ODS-5-B S-5 120A, YMC) with 80% methanol as elution solvent.
Active fractions containing EI-2128-1 were evaporated, and EI-2128-1 (107.6mg) was obtained as white powder. Table 1 . EI-2128-1 was readily soluble in methanol, acetonitrile, and chloroform. The molecular formula of EI-2128-1 was determined by the high resolution FAB-MS to be C23H35NO6. The 13C NMR spectrum (Table 2) showed 23 carbon signals which were assigned to seven methines, seven methylenes, three The relative stereochemistry of the spiro ring system was established by the NOESY experiment. Cross peaks were observed between H-6 and H-7, H-9 and H-10, H-6 and Hb-4, Hb-4 and N-H, H-10 and Ha-4, H-10 and H-3, H-2 and H-3, H-2 and Ha-4, and Ha-4 and H-3, respectively. These observations indicated that H-2, H-3, and Ha-4 are on the same face, and the two epoxide groups and lactol ring oxygen were on the same orientation. The relative stereochemistry of the spiro ring system of EI-2128-1 were same as aranorosin. The total synthesis of aranorosin17)
revealed the absolute as well as the relative configuration of the natural product, including C6' configuration.
Stereochemical studies of C4' and C5' configuration of EI-2128-1 are now in progress. The assay mixture was incubated for 2 hours at room temperature. Then the fluorescent intensity (excitationwave length: 370nm, emission-wave length: 440nm) of the assay mixtures was measured. Symbols indicate the ICE inhibition %. 
